We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Pharmacy/Biocompatible, injectable and self-healable MOF-based anti-freezing eutectogels for higher encapsulation and sustained release of the anticancer drug curcumin
PeriodicalsPharmacy

Biocompatible, injectable and self-healable MOF-based anti-freezing eutectogels for higher encapsulation and sustained release of the anticancer drug curcumin

Checking your access to this record.

Abstract & Overview

A MOF based eutectogel with antibacterial and antioxidant attributes, along with hemocompatibility, is used for the encapsulation and sustained release of curcumin.

Cite this record

Nildhara Parsana, Hiral Ukani, Dharmveer Singh Chauhan, Omar A. El Seoud, Sanjay Mehra, Arvind Kumar, et al. (2024). Biocompatible, injectable and self-healable MOF-based anti-freezing eutectogels for higher encapsulation and sustained release of the anticancer drug curcumin. RSC Pharmaceutics, 1(2), 317–332. https://doi.org/10.1039/d3pm00088e

Copy in another style

Parsana, N., Ukani, H., Chauhan, D. S., Seoud, O. A. E., Mehra, S., Kumar, A., Raje, N. H., & Malek, N. I. (2024). Biocompatible, injectable and self-healable MOF-based anti-freezing eutectogels for higher encapsulation and sustained release of the anticancer drug curcumin. RSC Pharmaceutics, 1(2), 317–332. https://doi.org/10.1039/d3pm00088e
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.